Lali Sharvadze
Invited Lecturer
Doctor
Department of Medicine
School of Health Sciences
- - Bachelor - -
Tbilisi State Medical University, - Faculty of Internal Diseases - - - 1986-05-09
diploma Institute, Tbilisi, Georgia - Residency in Infectious Diseases - - - 1995-05-04
Ministry of Health, Labour and Social Affairs of Georgia Licensure Examination in Specialty: Infectious Diseases - Infectious Diseases - - - 2001-01-08
Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia. - 2019
Three years of progress towards achieving hepatitis C elimination in the country of Georgia, April 2015 - March 2018. - 2019
HIV patients remain at high risk for advanced liver fibrosis after curing HCV infection - 2019
Non-alcoholic fatty liver disease (NAFLD) and related metabolic disorders among HIV-infected patients in the country of Georgia - 2019
Causes and outcomes of hospitalizations among HIV positive persons in Georgia's referral institution, 2012-2017 - 2019
Evaluation of the hepatitis C care cascade in the country of Georgia: monitoring 4 years of progress towards elimination - 2019
MANAGEMENT OF HEPATITIS C IN PRIMARY HEALTHCARE IN THE COUNTRY OF GEORGIA - 2019
Impact of hepatitis C virus antibody positivity on mortality and causes of death in people living with HIV in Georgia. - 2019
Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia. - 2019
Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs - Georgia, 2018. - 2019
Excellence in Viral Hepatitis Elimination - Lessons from Georgia - 2019
LDV/SOF/RBV is an effective first-line DAA regimen as well as retreating option for RF1_2k/1b patients within Georgian national hepatitis C elimination program - 2019
Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015–August 2018 - 2019
An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia’s corrections system, December 2013–April 2015 - 2019
Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study. - 2020
Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia. - 2020
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia. - 2020
Three years of progress toward achieving hepatitis C elimination in the country of Georgia, April 2015–March 2018. - 2020
Management of hepatitis C in primary healthcare in the country of Georgia. - 2020
Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-October 2019. - 2020
RETREATMENT FOR HCV: PRELIMINARY RESULTS FROM A RETROSPECTIVE ANALYSIS OF POOLED NATIONAL PROGRAM DATA ACROSS LOW-AND MIDDLE-INCOME COUNTRIES - 2020
Causes and outcomes of hospitalizations among people living with HIV in Georgia’s referral institution, 2012–2017. - 2021
Progress towards achieving hepatitis C elimination in the country of Georgia, April 2015–December 2020. - 2021
FIVE YEARS OF PROGRESS TOWARDS ACHIEVING HEPATITIS C ELIMINATION IN THE COUNTRY OF GEORGIA, APRIL 2015-APRIL 2021. - 2021
ASSOCIATION OF TREATED AND UNTREATED CHRONIC HEPATITIS C WITH THE INCIDENCE OF TUBERCULOSIS: A POPULATION-BASED COHORT STUDY IN THE COUNTRY OF GEORGIA. - 2021
Treatment of hepatitis C in primary health care in the country of Georgia. - 2022
The prevalence of hyperglycemia and its impact on mortality among people living with HIV in Georgia. - 2022
Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries. - 2022
Economic evaluation of the Hepatitis C virus elimination program in the country of Georgia, 2015 to 2017. - 2022
Association of Treated and Untreated Chronic Hepatitis C With the Incidence of Active Tuberculosis Disease: A Population-Based Cohort Study - 2022
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge - 2022
Hepatitis C care cascade among patients with and without tuberculosis: findings from nationwide programs in the country of Georgia, 2015-2020 - 2022
Five years of progress towards achieving hepatitis C elimination in the country of Georgia, April 2015-October 2021 - 2022
Treatment of hepatitis C in primary healthcare in the country of Georgia. - 2022
Optimal screening and linkage to care model to achieve hepatitis C elimination targets in Georgia. - 2022
A global research priority agenda to advance public health responses to fatty liver disease - 2023
Spontaneous clearance of hepatitis C virus infection in the country of Georgia, 2015–2021 - 2023
Late presentation of chronic hepatitis C for care in Georgia: data from the national hepatitis C elimination program - 2023
Progress towards achieving hepatitis C elimination in the country of Georgia. April 2015-December 2022. - 2023
Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015–2020 - 2023
Association of treated and untreated chronic hepatitis C with the incidence of active tuberculosis disease: a population-based cohort study. - 2023
Economic evaluation of the Hepatitis C virus elimination program in the country of Georgia, 2015 to 2017 - 2023
ASSOCIATION OF HEPATITIS-C WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA-A CASE STUDY - 2023
- 13-02-2019
- 04-03-2019
- 04-03-2019
- 18-03-2019
- 25-03-2019
- 25-03-2019
- 25-03-2019
- 03-06-2019
- 03-06-2019
- 03-06-2019
- 03-06-2019
- 03-06-2019
- 03-06-2019
- 12-08-2019
- 12-08-2019
- 04-03-2020
- 04-03-2020
- 04-03-2020
- 04-03-2020
- 18-03-2020
- 18-03-2020
- 24-03-2020
- 27-03-2020
- 06-04-2020
- 01-01-2021
- 01-01-2021
- 02-01-2021
- 02-01-2021
- 02-01-2021
- 02-01-2021
- 23-03-2022
- 09-06-2022
- 09-06-2022
- 22-06-2022
- 22-06-2022
- 22-06-2022
- 21-09-2022
- 21-09-2022
- 13-10-2022
- 24-12-2022
EUROPEAN MEETING ON HIV & HEPATITIS TREATMENT STRATEGIES & ANTIVIRAL DRUG RESISTANCE 2023 - 07-06-2023
Karchava M, Sharvadze L, Dvali N, Gatserelia L, Dzigua L, Abutidze ,Zhamutashvili M, Kipiani N, Chkhartishvili N, Tsertsvadze T - 07-06-2023
58th Annual Meeting of the European Association for the Study of the Liver (EASL 2023). - 21-06-2023
58th Annual Meeting of the European Association for the Study of the Liver (EASL 2023). - 21-06-2023
58th Annual Meeting of the European Association for the Study of the Liver (EASL 2023). - 21-06-2023
-
Infectious Diseases-MD234260E (
2023/2024;
2024/2025;
2025/2026;
)
Infectious diseases-MD4260E (
2019/2020;
2020/2021;
2021/2022;
2022/2023;
)
Infectious Diseases-MD234260E
